Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: Koolaide who wrote (114)	11/6/1997 9:53:00 PM
From: Jim Mac	Respond to of 413

Those were good points. Concerning the potential for price pressures in the LVC field, that's what happened in the U.K. after the market became saturated with lasers. However, that was during a time when the technology was first-generation, the results not as good, the demand not as strong as it presumably will be in U.S., and hyperopia was not available (hyperopes seem to respond more enthusiastically to laser vision correction's results than myopes). Also, the main operators know they need to dominate their respective markets, keep costs low, and maximize volume per laser, so maybe it won't happen here. Yes, it seems LVCI will be the low-cost operator, and will have the most flexibility, unlike LCAV and Beacon, for example, who rely on fixed stand-alone sites. I think the mobiles are being underestimated for their ability to generate low-risk, low-cost revenue. They seem to be the only real differentiator between LVCI and the rest of the pack.